Location The research team decided that Puerto Rico would be the most suitable place to test the pill. More specifically, the former municipality of
Río Piedras, Puerto Rico, where the first trial would take place in 1956. The second reason was that Puerto Rico was facing a tremendous population boom, along with high rates of poverty and unemployment. The birth control pill was offered as a solution to overpopulation, and was seen as a way for the United States government to test population control as a global policy.
Participants When Pincus and Rock began their experiment, over 200 women were registered to take part in the program. The women that were recruited for these trials were " …the poorest of the poor, had no place else to go, and, short of sterilization, no birth control options," The women were also not provided any help or care. Margaret Marsh described in her work how many of these women were exploited for their use. During the trial, these women still had the responsibility of caring for and providing for their families. Marsh describes how one woman was 30 years old with ten children, and a husband that "drank heavily and insisted on daily intercourse, but claimed to be too sick to work." Marsh also described a woman who had five children and a husband who was frequently hospitalized for mental illnesses. At times, this treatment left them unable to work or even care for their family and children.
Drug administration and side effects The women were administered 10 milligrams of the experimental combination of estrogen and progesterone, more commonly known as Enovid, the first contraceptive pill. The women participating in the trial began to experience side effects, but their complaints were deemed unreliable and outright dismissed by researchers. Some symptoms reported among patients included dizziness, vomiting,
nausea, headache, and menstrual irregularities; some of which were so severe that they required hospitalizations. After the trials in Puerto Rico, the drug was approved in the U.S. in 1957 for consumer use as a medication to treat severe menstrual side effects. The drug was approved as a female oral contraceptive, the first in the U.S., in May 1960. G.D. Searle and company profited greatly from widespread sales of the product, although the company was initially extremely hesitant to be associated with the trials in any way.
Deaths Three deaths occurred among patients who were taking the birth control drug during the trials. Despite strong circumstantial evidence that the pill was causing these unexpected deaths, they were not reported for two reasons. Firstly, those conducting the trial considered the deaths to be coincidental. Secondly, autopsies were never conducted on the bodies of the three women. == Enovid ==